Biosimilars Survey 2021

The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding switching from originator biologics to their biosimilars. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare professionals, and health policy decision-makers. We did similar surveys in 2015 and 2020 and are now asking for your current views.

This survey is open to residents of Alberta and British Columbia who were prescribed an originator biologic but were made to switch to a biosimilar based on government policy changes. In these provinces, the policy has changed to only provide public coverage for the biosimilar and no longer provides any coverage for the originator biologic. It is also open to parents/caregivers of a person who has had their medication switched.

Want to learn more about biologics and biosimilars? Visit our biosimilars page to watch a video, view infographs, and read a wide variety of articles and reports about this topic.